SATELLITE SYMPOSIUM

SPONSORED BY

SATURDAY

18

SEPTEMBER

Efanesoctocog alfa (BIVV001): exploring normalised haemostasis in haemophilia

Chairs: Jan Astermark (Sweden)

14:00

Welcome and introduction
Jan Astermark (Sweden)

14:10

Navigating uncertainty: remaining challenges in haemophilia care today
Katharina Holstein (Germany)

14:25

Efanesoctocog alfa (BIVV001): a new class of factor replacement therapy
Annemieke Willemze (Sanofi Genzyme)

14:35

The path to normalisation in haemophilia
Elena Santagostino (Sobi)

14:50

Questions & Answers
Jan Astermark (Sweden)